Dr. Alesandro Santin Discusses Treatment for Endometrial Cancer
Since their arrivals at Yale within the past six years, Patricia LoRusso (right) and Joseph Paul Eder (center)–shown conferring with Clinical Research Coordinator Alexandra Minnella–have overseen a sharp increase in the number of clinical trials conducted by the Phase I Program at Yale Cancer Center.
Women who have one or both breasts removed to treat cancer may have unrealistic expectations about how they’ll feel after that surgery and after breast reconstruction, if they choose that option, a U.S. study suggests.
New research by Yale Cancer Center (YCC) researchers shows a majority of pediatric cancer providers endorse the potential use of medical marijuana for children with advanced cancer, although providers who are legally eligible to certify its use are more cautious than those who aren’t.
For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which initially was effective against their tumors.